Federated Hermes’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,606
| Closed | -$6.67K | – | 2269 |
|
|
2023
Q1 | $6.67K | Buy |
3,606
+367
| +11% | +$679 | ﹤0.01% | 1907 |
|
|
2022
Q4 | $3.6K | Buy |
3,239
+2,929
| +945% | +$3.25K | ﹤0.01% | 1959 |
|
|
2022
Q3 | $1K | Buy |
+310
| New | +$1K | ﹤0.01% | 2117 |
|
|
2020
Q4 | – | Sell |
-64
| Closed | -$1K | – | 2372 |
|
|
2020
Q3 | $1K | Sell |
64
-40,207
| -100% | -$628K | ﹤0.01% | 2218 |
|
|
2020
Q2 | $278K | Sell |
40,271
-9,284
| -19% | -$64.1K | ﹤0.01% | 1585 |
|
|
2020
Q1 | $235K | Buy |
49,555
+46,653
| +1,608% | +$221K | ﹤0.01% | 1548 |
|
|
2019
Q4 | $25K | Buy |
+2,902
| New | +$25K | ﹤0.01% | 1810 |
|
|
2019
Q3 | – | Sell |
-362
| Closed | -$2K | – | 2313 |
|
|
2019
Q2 | $2K | Sell |
362
-2,818
| -89% | -$15.6K | ﹤0.01% | 2086 |
|
|
2019
Q1 | $20K | Sell |
3,180
-4,574
| -59% | -$28.8K | ﹤0.01% | 1779 |
|
|
2018
Q4 | $26K | Buy |
7,754
+5,764
| +290% | +$19.3K | ﹤0.01% | 1730 |
|
|
2018
Q3 | $13K | Buy |
1,990
+1,752
| +736% | +$11.4K | ﹤0.01% | 1913 |
|
|
2018
Q2 | $2K | Buy |
+238
| New | +$2K | ﹤0.01% | 2119 |
|